Narayanan Srihari

6.5k total citations
8 papers, 128 citations indexed

About

Narayanan Srihari is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Narayanan Srihari has authored 8 papers receiving a total of 128 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Narayanan Srihari's work include Renal cell carcinoma treatment (4 papers), Prostate Cancer Treatment and Research (3 papers) and Renal and related cancers (3 papers). Narayanan Srihari is often cited by papers focused on Renal cell carcinoma treatment (4 papers), Prostate Cancer Treatment and Research (3 papers) and Renal and related cancers (3 papers). Narayanan Srihari collaborates with scholars based in United Kingdom, Austria and Greece. Narayanan Srihari's co-authors include Karen Sanders, Gianfilippo Bertelli, Noel W. Clarke, Matthew R. Sydes, Malcolm D. Mason, John Dwyer, Gordana Jovic, Alison Birtle, George N. Thalmann and David P. Dearnaley and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.

In The Last Decade

Narayanan Srihari

8 papers receiving 124 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Narayanan Srihari United Kingdom 5 69 48 47 36 23 8 128
Kristina Williams United States 7 52 0.8× 28 0.6× 38 0.8× 50 1.4× 15 0.7× 10 144
N. Varol United Kingdom 7 76 1.1× 22 0.5× 89 1.9× 57 1.6× 37 1.6× 26 294
Patrícia Xavier Santi Brazil 10 32 0.5× 58 1.2× 173 3.7× 25 0.7× 19 0.8× 17 263
Thomas H. Openshaw United States 7 37 0.5× 111 2.3× 98 2.1× 18 0.5× 11 0.5× 12 192
Pablo Borrega Spain 8 116 1.7× 93 1.9× 93 2.0× 72 2.0× 29 1.3× 28 243
Mirjam de With Netherlands 8 30 0.4× 20 0.4× 88 1.9× 71 2.0× 8 0.3× 13 186
Radka Platte United Kingdom 4 84 1.2× 53 1.1× 59 1.3× 68 1.9× 9 0.4× 4 242
Cheryl J. Smith United States 8 34 0.5× 41 0.9× 74 1.6× 47 1.3× 8 0.3× 10 169
Antonio Verde Italy 7 119 1.7× 36 0.8× 65 1.4× 55 1.5× 39 1.7× 14 192
Marjorie Baciuchka France 7 70 1.0× 40 0.8× 51 1.1× 49 1.4× 13 0.6× 14 158

Countries citing papers authored by Narayanan Srihari

Since Specialization
Citations

This map shows the geographic impact of Narayanan Srihari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narayanan Srihari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narayanan Srihari more than expected).

Fields of papers citing papers by Narayanan Srihari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narayanan Srihari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narayanan Srihari. The network helps show where Narayanan Srihari may publish in the future.

Co-authorship network of co-authors of Narayanan Srihari

This figure shows the co-authorship network connecting the top 25 collaborators of Narayanan Srihari. A scholar is included among the top collaborators of Narayanan Srihari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narayanan Srihari. Narayanan Srihari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
2.
Procopio, Giuseppe, Aristotelis Bamias, Manuela Schmidinger, et al.. (2019). Real-world Effectiveness and Safety of Pazopanib in Patients With Intermediate Prognostic Risk Advanced Renal Cell Carcinoma. Clinical Genitourinary Cancer. 17(3). e526–e533. 8 indexed citations
3.
Schmidinger, Manuela, Aristotelis Bamias, Giuseppe Procopio, et al.. (2019). Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study). The Oncologist. 24(4). 491–497. 22 indexed citations
4.
Procopio, Giuseppe, Aristotelis Bamias, Manuela Schmidinger, et al.. (2018). Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study). Annals of Oncology. 29. viii313–viii313. 1 indexed citations
5.
Bamias, Aristotelis, Petri Bono, Giuseppe Procopio, et al.. (2014). Principal: A prospective observational study of real-world treatment patterns and treatment outcomes in patients with advanced or metastatic renal cell carcinoma (mRCC) receiving pazopanib.. Journal of Clinical Oncology. 32(15_suppl). TPS4600–TPS4600. 1 indexed citations
6.
James, Nicholas D., Matthew R. Sydes, Malcolm D. Mason, et al.. (2012). Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial. The Lancet Oncology. 13(5). 549–558. 68 indexed citations
7.
James, Nicholas D., Matthew R. Sydes, Malcolm D. Mason, et al.. (2012). Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: First results from STAMPEDE (MRC PR08, CRUK/06/019), a randomized controlled trial.. Journal of Clinical Oncology. 30(5_suppl). 26–26. 3 indexed citations
8.
Hartley, A., Selvaraj Giridharan, Narayanan Srihari, C. McConkey, & J I Geh. (2003). Impaired postoperative neutrophil leucocytosis and acute complications following short course preoperative radiotherapy for operable rectal cancer. European Journal of Surgical Oncology. 29(2). 155–157. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristina Williams Breakdown of academic impact, for papers by N. Varol Breakdown of academic impact, for papers by Patrícia Xavier Santi Breakdown of academic impact, for papers by Thomas H. Openshaw Breakdown of academic impact, for papers by Pablo Borrega Breakdown of academic impact, for papers by Mirjam de With Breakdown of academic impact, for papers by Radka Platte Breakdown of academic impact, for papers by Cheryl J. Smith Breakdown of academic impact, for papers by Antonio Verde Breakdown of academic impact, for papers by Marjorie Baciuchka
Rankless by CCL
2026